|
KR100830859B1
(en)
*
|
2000-04-27 |
2008-05-21 |
아스텔라스세이야쿠 가부시키가이샤 |
Imidazopyridine derivatives and pharmaceutical compositions containing the same
|
|
MXPA04001399A
(en)
|
2001-08-13 |
2004-05-27 |
Janssen Pharmaceutica Nv |
2-amino-4,5-trisubstituted thiazolyl derivatives.
|
|
DE10247271A1
(en)
*
|
2002-10-10 |
2004-08-26 |
Grünenthal GmbH |
Use of new and known 7-(methyl or trifluoromethyl)-imidazo-(1,2-a)-pyridines as nitrogen monoxide synthase inhibitors useful e.g. for treating migraine, neurodegenerative diseases, inflammatory pain, diabetes or cancer
|
|
US20090209573A1
(en)
*
|
2004-10-28 |
2009-08-20 |
Irm Llc |
Compounds and compositions as hedgehog pathway modulators
|
|
CN101098870B
(en)
|
2004-11-08 |
2010-11-03 |
万有制药株式会社 |
Novel Fused Ring Imidazole Derivatives
|
|
US20070155738A1
(en)
|
2005-05-20 |
2007-07-05 |
Alantos Pharmaceuticals, Inc. |
Heterobicyclic metalloprotease inhibitors
|
|
US7563797B2
(en)
|
2006-08-28 |
2009-07-21 |
Forest Laboratories Holding Limited |
Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands
|
|
WO2008078091A1
(en)
|
2006-12-22 |
2008-07-03 |
Astex Therapeutics Limited |
Bicyclic heterocyclic compounds as fgfr inhibitors
|
|
CA2672213C
(en)
|
2006-12-22 |
2016-02-16 |
Astex Therapeutics Limited |
Bicyclic amine derivatives as protein tyrosine kinase inhibitors
|
|
JP2010531875A
(en)
*
|
2007-06-26 |
2010-09-30 |
ギリード・サイエンシズ・インコーポレーテッド |
Imidazopyridinylthiazolyl histone deacetylase inhibitors
|
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
|
GB0720041D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
|
GB0810902D0
(en)
|
2008-06-13 |
2008-07-23 |
Astex Therapeutics Ltd |
New compounds
|
|
EP2306836B1
(en)
*
|
2008-07-01 |
2016-09-07 |
PTC Therapeutics, Inc. |
Bmi-1 protein expression modulators
|
|
US8344018B2
(en)
|
2008-07-14 |
2013-01-01 |
Gilead Sciences, Inc. |
Oxindolyl inhibitor compounds
|
|
AU2009271003A1
(en)
|
2008-07-14 |
2010-01-21 |
Gilead Sciences, Inc. |
Imidazolylpyrimidine compounds as HDAC and/or CDK inhibitors
|
|
WO2010009155A2
(en)
|
2008-07-14 |
2010-01-21 |
Gilead Colorado, Inc. |
Fused heterocyclyc inhibitor compounds
|
|
US8088771B2
(en)
|
2008-07-28 |
2012-01-03 |
Gilead Sciences, Inc. |
Cycloalkylidene and heterocycloalkylidene inhibitor compounds
|
|
GB0906472D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
|
GB0906470D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
|
US8283357B2
(en)
|
2009-06-08 |
2012-10-09 |
Gilead Sciences, Inc. |
Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds
|
|
CA2763786C
(en)
|
2009-06-08 |
2014-09-30 |
Gilead Sciences, Inc. |
Alkanoylamino benzamide aniline hdac inihibitor compounds
|
|
US20120220581A1
(en)
|
2009-10-30 |
2012-08-30 |
Janssen-Cilag, S.A. |
IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
|
|
AR080754A1
(en)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
IMIDAZO DERIVATIVES (1,2-A) PIRAZINA AND ITS USE AS PDE10 INHIBITORS
|
|
WO2012162468A1
(en)
*
|
2011-05-25 |
2012-11-29 |
Janssen Pharmaceutica Nv |
Thiazol derivatives as pro -matrix metalloproteinase inhibitors
|
|
EP2723744B1
(en)
|
2011-06-27 |
2016-03-23 |
Janssen Pharmaceutica, N.V. |
1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES
|
|
RU2657540C2
(en)
|
2012-06-26 |
2018-06-14 |
Янссен Фармацевтика Нв |
Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4]triazolo[4,3-a]quinoxaline compounds and pde 10 inhibitors for use in treatment of neurological or metabolic disorders
|
|
ES2607184T3
(en)
|
2012-07-09 |
2017-03-29 |
Janssen Pharmaceutica, N.V. |
Phosphodiesterase 10 enzyme inhibitors
|
|
WO2014072714A1
(en)
*
|
2012-11-07 |
2014-05-15 |
Karus Therapeutics Ltd |
Novel histone deacetylase inhibitors and their use in therapy
|
|
US9862685B2
(en)
|
2013-05-10 |
2018-01-09 |
Karus Therapeutics Limited |
Histone deacetylase inhibitors
|
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
ES2672797T3
(en)
|
2014-02-13 |
2018-06-18 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
PH12020552066A1
(en)
|
2014-02-13 |
2022-05-11 |
Incyte Corp |
Cyclopropylamines as lsd1 inhibitors
|
|
RS59534B1
(en)
|
2014-02-13 |
2019-12-31 |
Incyte Corp |
Cyclopropylamines as lsd1 inhibitors
|
|
US9758523B2
(en)
|
2014-07-10 |
2017-09-12 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
|
|
TWI687419B
(en)
|
2014-07-10 |
2020-03-11 |
美商英塞特公司 |
Imidazopyridines and imidazopyrazines as LSD1 inhibitors
|
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
WO2016007736A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyrazines as lsd1 inhibitors
|
|
GB201419264D0
(en)
|
2014-10-29 |
2014-12-10 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201419228D0
(en)
|
2014-10-29 |
2014-12-10 |
Karus Therapeutics Ltd |
Compounds
|
|
EP3626720A1
(en)
|
2015-04-03 |
2020-03-25 |
Incyte Corporation |
Heterocyclic compounds as lsd1 inhibitors
|
|
MX389824B
(en)
|
2015-08-12 |
2025-03-20 |
Incyte Holdings Corp |
SALTS OF A LYSINE-SPECIFIC DIMETHYLASE 1 INHIBITOR (LSD1).
|
|
IL262488B
(en)
|
2016-04-22 |
2022-08-01 |
Incyte Corp |
Formulations of an lsd1 inhibitor
|
|
US10968200B2
(en)
|
2018-08-31 |
2021-04-06 |
Incyte Corporation |
Salts of an LSD1 inhibitor and processes for preparing the same
|
|
EP3962915B1
(en)
*
|
2019-04-30 |
2024-09-04 |
Ustav Organicke Chemie A Biochemie Av Cr, V.v.i. |
Selective ligands of human constitutive androstane receptor
|